(19)
(11) EP 1 149 080 A2

(12)

(88) Date of publication A3:
18.01.2001

(43) Date of publication:
31.10.2001 Bulletin 2001/44

(21) Application number: 99964980.9

(22) Date of filing: 10.11.1999
(51) International Patent Classification (IPC)7C07D 221/00, A61K 31/473, A61P 35/00
(86) International application number:
PCT/US9926/809
(87) International publication number:
WO 0034/245 (15.06.2000 Gazette 2000/24)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.12.1998 US 111243 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventor:
  • WEIGEL, Leland, Otto
    Indianapolis, IN 46254 (US)

(74) Representative: Burnside, Ivan John et al
Eli Lilly and Company LimitedLilly Research CentreErl Wood Manor
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) CRYSTALLINE FORM OF BENZOQUINOLINE-3-ONE DERIVATIVE AS INHIBITOR OF 5-ALPHA REDUCTASE